SCHEMBL6203985

SCHEMBL6203985

COc1cccc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29635640 1.00
SCHEMBL70822 1.00
SCHEMBL1794813 0.98 ACHE (0.54)
Water SCHEMBL27909580 0.98 ACHE (0.54)
SCHEMBL9628833 0.91 RELA (0.58)
Naphthalene SCHEMBL10873174 0.91 CYP2A6 (0.59)
SCHEMBL4621505 0.91 NPC1 (0.51)
SCHEMBL792094 0.87 CYP1A1 (0.57)
Boric Acid SCHEMBL27272586 0.86 ENPP2 (0.52)
Phenol SCHEMBL28303203 0.86 TSHR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed